Domov › Rak dojke › Nevada › Reno

Klinične študije za Rak dojke v Reno, NV

13 študij za Rak dojke išče udeležence na lokacijah v Reno in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Vključevanje udeležencevFaza 3

Cancer Care Specialists, Reno

Starost 18–100 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Renown Regional Medical Center, Reno
Saint Mary's Regional Medical Center, Reno
Carson Tahoe Regional Medical Center, Carson City · 25 mi stran

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Vključevanje udeležencevFaza 2

Cancer Care Specialists, Reno

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06369285

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Vključevanje udeležencevFaza 3

Renown Regional Medical Center ( Site 0041), Reno

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06966700

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Vključevanje udeležencevFaza 1/2

Renown Regional Medical Center, Reno

Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT03424005

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Vključevanje udeležencevFaza 3

Research Site, Reno

Starost 18–130 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07647328

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Vključevanje udeležencevFaza 3

Renown Health Medical Oncology, Reno

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06982521

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Vključevanje udeležencevOpazovalna študija

Cancer Care Specialist of Reno, Reno

Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07211178

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Vključevanje udeležencevFaza 3

Renown Regional Medical Center, Reno
Saint Mary's Regional Medical Center, Reno
Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · 24 mi stran
in še 1

Starost 18–60 · Ženske · Posodobljeno 2. sep. 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Vključevanje udeležencevFaza 3

Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · 24 mi stran

Starost 18–50 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06748222

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Vključevanje udeležencevFaza 3

Renown Regional Medical Centre, Reno
Cancer Care Specialists, Reno

Starost 18 in več · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT05696626

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Vključevanje udeležencevFaza 3

Renown Regional Medical Center, Reno
Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · 24 mi stran

Starost 50–70 · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT04852887

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Vključevanje udeležencevFaza 1

Renown Regional Medical Center, Reno

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2025 · NCT05216432

Študije za Rak dojke v drugih mestih

Druge študije v Reno

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.